Executive Director, Equity Research @ Cibc Capital Markets (January 2005 - January 2008)
Vice President, Senior Health Care Analyst @ (January 2004 - January 2005)
Vice-President, Equity Research @ (January 2000 - January 2004)
Partner and Investment Analyst @ Dlouhy Investments (January 1997 - January 2000)
Equity Research Associate, Biotechnology @ Lehman Brothers (January 1996 - January 1997)
Joseph Walewicz Education
McGill University
Master of Business Administration (Finance)
1993-1996
Queen's University
Bachelor of Science (Economics, Biochemistry)
1988-1993
Joseph Walewicz Skills
Investments
Due Diligence
Marketing Strategy
Entrepreneurship
Oncology
Clinical Development
Capital Markets
Equity Research
Market Analysis
Pharmaceutical Industry
Chartered Financial Analyst
Licensing
Corporate Development
Corporate Finance
Research
Microsoft Excel
Business Planning
Lifesciences
Competitive Analysis
Finance
Business Development
Equities
Healthcare
Medical Devices
Strategy
Mergers and Acquisitions
New Business Development
Vaccines
Business Strategy
Drug Development
Technology Transfer
Securities
Pharmaceutics
Training
Strategic Planning
Investor Relations
Private Equity
Valuation
Financial Modeling
Venture Capital
Market Research
Mergers
Commercialization
Biotechnology
Start Ups
Joseph Walewicz Summary
Joseph Walewicz, based in Montreal, QC, CA, is currently a Chief Executive Officer at NeuPath Health (TSXV:NPTH). Joseph Walewicz brings experience from previous roles at Neupath Health (Tsxv:npth), Fibrocor Therapeutics and Clementia Pharmaceuticals Inc.. Joseph Walewicz holds a 1993 - 1996 Master of Business Administration in Finance @ McGill University. With a robust skill set that includes Investments, Due Diligence, Marketing Strategy, Entrepreneurship, Oncology and more. Joseph Walewicz has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Joseph Walewicz?
Find contact details for 700 million professionals.